Get Premium to unlock powerful stock data
NAS:OBSV (Switzerland)  
ObsEva SA logo

ObsEva SA

$ 1.82 +0.06 (+3.41%) 10:08 PM EST
P/E:
At Loss
P/B:
5.62
Market Cap:
$ 152.33M
Enterprise V:
$ 123.64M
Volume:
284.87K
Avg Vol (2M):
498.69K
Also Trade In:
Volume:
284.87K
Market Cap $:
152.33M
PE Ratio:
At Loss
Avg Vol (2-Month):
498.69K
Enterprise Value $:
123.64M
PB Ratio:
5.62
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

ObsEva SA
NAICS : 325412 SIC : 2834
Chemin des Aulx, 12, Plan-les-Ouates, Geneva, CHE, 1228
Description
ObsEva SA is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. The company is focused on providing therapeutic solutions for women between the ages of 15 and 49 who suffer from reproductive health conditions that affect their quality of life, ability to conceive or that complicate pregnancy and the health of newborns. The is developing OBE2109 as a novel, oral gonadotropin-releasing hormone, or GnRH, receptor antagonist, for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women.
Name Current Vs Industry Vs History
Cash-To-Debt 1.7
Equity-to-Asset 0.31
Debt-to-Equity 1.21
Debt-to-EBITDA -0.77
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 58.93
9-Day RSI 52.99
14-Day RSI 52.46
6-1 Month Momentum % -0.49
12-1 Month Momentum % -30.51

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.09
Quick Ratio 3.09
Cash Ratio 2.77

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -22.5
Name Current Vs Industry Vs History
ROE % -128.28
ROA % -53.13
ROIC % -164.74
ROC (Joel Greenblatt) % -5106.95
ROCE % -59.62

Financials (Next Earnings Date:2022-08-05 Est.)

OBSV's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:OBSV

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -0.64
Beta 0.63
Volatility % 51.42
14-Day RSI 52.46
14-Day ATR ($) 0.131309
20-Day SMA ($) 1.85
12-1 Month Momentum % -30.51
52-Week Range ($) 1.08 - 3.58
Shares Outstanding (Mil) 83.7

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

ObsEva SA Filings

Document Form Filing Date
No Filing Data

Headlines

See More